Pharmacodynamics & Drug Receptors Flashcards
Pharmacodynamics
effects of drugs on body
Receptor
molecule to which a drug binds to bring about a change in function
Receptor Site
specific region of the receptor molecule to which drug binds (site has high affinity for the drug)
Inert Binding Molecule or Site
molecule to which a drug may bind without changing any function (binds but exerts no fxn, may keep other things from binding)
Spare Receptor
receptor that doesnt bind drug when concentration is sufficient to produce max effect (max drug response from occupying less than half of the receptors)
Effector
what accomplishes the final change, can be part of receptor molecule or a separate molecule
Ex: channel or enzyme molecule
Emax (maximal efficacy)
max effect that can be achieved w/ particular drug regardless of dose
Potency
amnt of drug needed to produce given effect, determined mainly by the affinity of the receptor for the drug, and number of receptors available
Graded dose-response Curve
graph of increasing response to increasing drug conc.
Quantal dose-response
graph of fraction of population that shows specified response at progresively increasing dose (used to determine how many ppl will be effected negatively from certain doses)
EC50
CONCENTRATION that causes 50% of max effect or toxicity
ED50
DOSE that causes 50% of max effect or toxicity
TD50/TC50
median toxic dose/concentration at which toxicity occurs in 50% of cases
LD50/LC50
median lethal dose required to kill half the members of a tested population
Kd
concentration of a drug that binds 50% of receptors in the system
Bmax
max number of receptors bound
Agonist
ACTIVATES receptor upon BINDING
Partial Agonist
drug that binds to receptor but produces smaller effect at full dosage than full agonist (will give partial result, not max effect)
Allosteric Agonist
binds to receptor molecule w/out interfering w/normal agonist binding but alters response to normal agonist (binds to receptor, doesnt have effect nor does it interfere w/normal agonist binding but it will block the normal agonsits effect)
Antagonist
binds WITHOUT activating its receptor, PREVENTS activation by agonist (can be overcome by giving AGONIST of higher conc.)
Irreversible Antagonist
cannot be overcome by increasing AGONIST conc. its actions are irreversible (“destroys receptor”)
Physiologic Antagonist
drug that counters effects of another drug by binding to a DIFFERENT receptor and causing OPPOSING effects
Chemical Antagonist
drug that counters effects of another by binding the AGONIST DRUG (not receptor)
Allosteric Antagonist
drug that binds to receptor molecule w.out interfering w/normal antagonist binding, but ALTERS THE RESPONSE TO THE NORMAL ANTAGONIST
Therapeutic Index (TI)
relates dose of drug required to produce desired effect to dose that produces undesired effect
Narrow TI=range of best effect VERY close to range of toxic effect, dose careful, narrow window
Signaling
once AGONIST drug has bound to receptor, some effector mechanism is activated
5 Major Types of Transmembrane-signaling Mechanisms
Transmembrane Diffusion Transmembrane Enzyme Receptors Cytokine Receptors Transmembrane Channels G Protein Couples Receptors
Transmembrane Diffusion
drug diffuses across membrane, and binds to an INTRACELLULAR receptor (drug tends to be lipid-soluble)
Transmembrane Enzyme Receptors
drug effects MEMBRANE-SPANNING enzyme, binds outside of cell, signals through receptor to the inside of cell where process will occur
Cytokine Receptors
drug binds outside cell, signals receptor, the receptor isnt necessarily doing the action, but it tells signal on inside (tyrosine kinase molecule JAK) to do the action (site acts as messenger)
the JAK’s are activated and phosphorylate STAT which travel to nucleus (effectors)
Membrane Ion Channels
drug binds to receptor, receptor will open or close (directly cause opening of channel)
Drug can also modify channels response to another agent
the channel acts as both receptor and effector
G Protein Coupled Receptors
drug cant directly bind to the effector, so it binds to receptor that is linked to effector.
receptor activates g-proteins–>stimulate/inhibit the effector
Receptor Regulation
receptors are regulated by number, location & sensitivity.
Body can halt production of receptors if it thinks theres too many or it can make more if there arent enough
Tachyphylaxis
acute decrease in response to a drug
frequent/continuous exposure to agonist, resulting in short-term reduction of receptor response
“overstimulate receptors until they are “numb”
somtimes can be overcome by increasing dose
Downregulation
long term reduction in receptor # which occur in response to continuous exposure to AGONIST
(body feels like it doesnt need receptors so it stops producing them)
Upregulation
increase in receptor # occurs when receptor activation is blocked by ANTAGONIST
body doesnt know receptors are blocked, thinks there arent enough receptors so it makes more
if pt were to DC a drug like this, they will have huge rebound effect becuase now there are even more receptors